The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales

McCarthy, EM, Sutton, E, Nesbit, S et al. (18 more authors) (2017) The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. Rheumatology, 56 (6). pp. 1041-1043. ISSN 1462-0324

Metadata

Authors/Creators:
  • McCarthy, EM
  • Sutton, E
  • Nesbit, S
  • Parker, B
  • Jayne, D
  • Griffiths, B
  • Isenberg, DA
  • Rahman, A
  • Gordon, C
  • D’Cruz, DP
  • Rhodes, B
  • Lanyon, P
  • Vital, EM https://orcid.org/0000-0003-1637-4755
  • Yee, C-S
  • Edwards, CJ
  • Teh, L-S
  • Akil, M
  • McHugh, NJ
  • Zoma, A
  • Bruce, IN
  • British Isles Lupus Assessment Group Biologics Register,
Dates:
  • Published: 1 June 2017
  • Published (online): 18 April 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2018 15:05
Last Modified: 25 Sep 2018 15:05
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kex044

Commentary/Response Threads

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics